N-terminal cysteine motif (N-Cys)

N-terminal cysteine motifs are specific structural arrangements where a cysteine residue is located at the absolute amino terminus of a peptide or protein, exposing a unique 1,2-aminothiol functional group. This motif plays a pivotal role in the N-degron pathway (formerly the N-end rule pathway), acting as a degradation signal that regulates the stability of proteins involved in oxygen sensing, G-protein signaling, and cardiovascular homeostasis (Varshavsky, 2011; Tasaki et al., 2012). Biologically, the N-terminal cysteine is often modified through oxidation by cysteamine dioxygenase (ADO) and subsequent arginylation by ATE1, marking the protein for recognition by E3 ubiquitin ligases and subsequent proteasomal destruction (Nguyen et al., 2018). In the field of chemical biology, this motif is exploited as a highly selective "chemical handle" for site-specific bioconjugation, most notably in Native Chemical Ligation (NCL) and 2-cyanobenzothiazole (CBT) click chemistry (Dawson et al., 1994; Liang et al., 2010). These applications allow for the construction of large synthetic proteins, the creation of antibody-drug conjugates, and the development of "smart" probes that self-assemble into nanofibers upon encountering N-terminal cysteines in vivo. Therapeutic strategies utilizing this motif are particularly relevant in oncology for localized drug delivery, where CBT-functionalized drugs can undergo controlled polymerization in the presence of N-terminal cysteines. Because the 1,2-aminothiol functionality is distinct from the thiol group of internal cysteine residues, it allows for highly selective modifications even in complex biological environments.

Other names

1,2-aminothiol motifN-terminal CysN-end rule cysteineN-terminal cysteinyl residueN-degron cysteine

Bioorthogonal covalent coupling via 1,2-aminothiol condensation (e.g., with CBT to form benzothiazoles) or transthioesterification followed by S-to-N acyl shift (Native Chemical Ligation) (Liang et al., 2010; Dawson et al., 1994).